|
Academic: Max Delbrück Center for Molecular Medicine (MDC), Berlin
(»Add to Infobox)


 |
 |
 |
General description: Founded in 1992, the MDC is a young research institute funded by the German Federal government and the State of Berlin. It is a member of the Helmholtz Association of National Research Centers (Helmholtz-Gemeinschaft Deutscher Forschungszentren (HGF)). Research at the MDC focuses on the molecular analysis and treatment of the most prevalent diseases in the population, namely cardiovascular diseases, cancer, and neurological diseases. Two research clinics of the Charité University Medical School are connected to the MDC. Together with its partner institute, the Institute for Molecular Pharmacology (FMP) and the approximately 30 biotech companies on the Buch Campus, the MDC has virtually the entire range of research and clinical tools for molecular medicine at its disposal.
|
 |


|

| RESEARCH GROUP(S) (1/1) |
 |

Thomas Sommer's Group
|
|
|








|